Case - Bladder Paraganglioma in a Pediatric Patient

Overview

Journal Can Urol Assoc J

Specialty Urology

Date 2018 Feb 7

PMID 29405904

Citations 1

Authors

Armaan K Malhotra

Ryan Yan

Raymond Tabeshi

Helen Nadel

Henry Tran

John Masterson

Affiliations

Soon will be listed here.

Citing Articles

A rare case of bladder paraganglioma treated successfully with robotic partial cystectomy.

Shekhda K, Palan J, Albor C, Wan S, Chung T Endocr Oncol. 2025; 5(1):e240044.

PMID: 39810845 PMC: 11728871. DOI: 10.1530/EO-24-0044.

Incidental diagnosis of nonfunctional bladder paraganglioma: a case report and literature review.

Tu X, Zhang N, Zhuang X, Chen S, Luo X BMC Urol. 2021; 21(1):98.

PMID: 34238271 PMC: 8265019. DOI: 10.1186/s12894-021-00863-y.

References

Bhalani S, Casalino D, Manvar A . Paraganglioma of the bladder. J Urol. 2011; 186(1):279-80. DOI: 10.1016/j.juro.2011.04.032. View

Marzola M, Chondrogiannis S, Colletti P, Rubello D . Succinate dehydrogenase mutation-related paragangliomas: conventional versus PET/CT diagnostic work-up. Nucl Med Commun. 2015; 36(7):657-65. DOI: 10.1097/MNM.0000000000000297. View

Semenza G . HIF-1 and human disease: one highly involved factor. Genes Dev. 2000; 14(16):1983-91. View

Huang H, Abraham J, Hung E, Averbuch S, Merino M, Steinberg S . Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients. Cancer. 2008; 113(8):2020-8. PMC: 9094399. DOI: 10.1002/cncr.23812. View

Thrasher J, Rajan R, Perez L, Humphrey P, Anderson E . Pheochromocytoma of urinary bladder: contemporary methods of diagnosis and treatment options. Urology. 1993; 41(5):435-9. DOI: 10.1016/0090-4295(93)90503-3. View

Vanderveen K, Thompson S, Callstrom M, Young Jr W, Grant C, Farley D . Biopsy of pheochromocytomas and paragangliomas: potential for disaster. Surgery. 2009; 146(6):1158-66. DOI: 10.1016/j.surg.2009.09.013. View

Timmers H, Kozupa A, Eisenhofer G, Raygada M, Adams K, Solis D . Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2007; 92(3):779-86. DOI: 10.1210/jc.2006-2315. View

Harari A, Inabnet 3rd W . Malignant pheochromocytoma: a review. Am J Surg. 2010; 201(5):700-8. DOI: 10.1016/j.amjsurg.2010.04.012. View

Piedrola G, Lopez E, Rueda M, Lopez R, Serrano J, Sancho M . Malignant pheochromocytoma of the bladder: current controversies. Eur Urol. 1997; 31(1):122-5. DOI: 10.1159/000474432. View

10.

ZIMMERMAN I, BIRON R, Macmahon H . Pheochromocytoma of the urinary bladder. N Engl J Med. 1953; 249(1):25-6. DOI: 10.1056/NEJM195307022490106. View

11.

Ueberberg B, Tourne H, Redmann A, Redman A, Walz M, Schmid K . Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland. Horm Metab Res. 2005; 37(12):722-8. DOI: 10.1055/s-2005-921092. View

12.

Kantorovich V, King K, Pacak K . SDH-related pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab. 2010; 24(3):415-24. PMC: 2939070. DOI: 10.1016/j.beem.2010.04.001. View

13.

Baima C, Casetta G, Vella R, Tizzani A . Bladder pheochromocytoma: a 3-year follow-up after transurethral resection (TURB). Urol Int. 2000; 65(3):176-8. DOI: 10.1159/000064868. View

14.

Das S, Bulusu N, Lowe P . Primary vesical pheochromocytoma. Urology. 1983; 21(1):20-5. DOI: 10.1016/0090-4295(83)90116-4. View

15.

Fishbein L, Nathanson K . Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. Cancer Genet. 2012; 205(1-2):1-11. PMC: 3311650. DOI: 10.1016/j.cancergen.2012.01.009. View

16.

Opocher G, Schiavi F . Genetics of pheochromocytomas and paragangliomas. Best Pract Res Clin Endocrinol Metab. 2010; 24(6):943-56. DOI: 10.1016/j.beem.2010.05.001. View

17.

Mannelli M . Management and treatment of pheochromocytomas and paragangliomas. Ann N Y Acad Sci. 2006; 1073:405-16. DOI: 10.1196/annals.1353.044. View

18.

Gottlieb E, Tomlinson I . Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer. 2005; 5(11):857-66. DOI: 10.1038/nrc1737. View

19.

Pepe G, Bombardieri E, Lorenzoni A, Chiti A . Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors. PET Clin. 2014; 9(1):11-26. DOI: 10.1016/j.cpet.2013.08.011. View

20.

Eisenhofer G, Siegert G, Kotzerke J, Bornstein S, Pacak K . Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas. Horm Metab Res. 2008; 40(5):329-37. PMC: 4714589. DOI: 10.1055/s-2008-1073156. View